Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125534781 | 12553478 | 1 | I | 2013 | 20160108 | 20160713 | 20160713 | PER | US-PERRIGO-16US000208 | PERRIGO | 0.00 | F | Y | 68.27000 | KG | 20160713 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125534781 | 12553478 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 30 MG, QD | U | 5DE1927 | 202319 | 30 | MG | MODIFIED-RELEASE CAPSULE, HARD | |||||
| 125534781 | 12553478 | 2 | C | VITAMIN B | VITAMIN B | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534781 | 12553478 | 3 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | 81MG | U | UNKNOWN | 0 | ||||||||
| 125534781 | 12553478 | 4 | C | GARLIC /01570501/ | GARLIC | 1 | Unknown | 2000 MG | U | UNKNOWN | 0 | ||||||||
| 125534781 | 12553478 | 5 | C | PRESERVISION | MINERALSVITAMINS | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534781 | 12553478 | 6 | C | VITAMIN C | ASCORBIC ACID | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534781 | 12553478 | 7 | C | BIOTIN | BIOTIN | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534781 | 12553478 | 8 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | 2000 | U | UNKNOWN | 0 | ||||||||
| 125534781 | 12553478 | 9 | C | FISH OIL/KRILL OIL | 2 | Unknown | 500MG/500MG | U | UNKNOWN | 0 | |||||||||
| 125534781 | 12553478 | 10 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534781 | 12553478 | 11 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | 2.5 MG | U | UNKNOWN | 0 | ||||||||
| 125534781 | 12553478 | 12 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Unknown | 5 MG | U | UNKNOWN | 0 | ||||||||
| 125534781 | 12553478 | 13 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125534781 | 12553478 | 1 | Dyspepsia |
| 125534781 | 12553478 | 2 | Supplementation therapy |
| 125534781 | 12553478 | 3 | Product used for unknown indication |
| 125534781 | 12553478 | 4 | Supplementation therapy |
| 125534781 | 12553478 | 5 | Macular degeneration |
| 125534781 | 12553478 | 6 | Supplementation therapy |
| 125534781 | 12553478 | 7 | Supplementation therapy |
| 125534781 | 12553478 | 8 | Supplementation therapy |
| 125534781 | 12553478 | 9 | Supplementation therapy |
| 125534781 | 12553478 | 10 | Hypersensitivity |
| 125534781 | 12553478 | 11 | Hypertension |
| 125534781 | 12553478 | 12 | Depression |
| 125534781 | 12553478 | 13 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125534781 | 12553478 | Incorrect dose administered | |
| 125534781 | 12553478 | Incorrect drug administration duration | |
| 125534781 | 12553478 | No adverse event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125534781 | 12553478 | 1 | 2013 | 0 |